{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:57:59Z","timestamp":1784282279784,"version":"3.55.0"},"reference-count":112,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001466","name":"American Urological Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001466","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.fct.2020.111133","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T11:34:29Z","timestamp":1579520069000},"page":"111133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Inflammation: Cause or consequence of chronic cholestatic liver injury"],"prefix":"10.1016","volume":"137","author":[{"given":"Benjamin L.","family":"Woolbright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/toxsci\/kfq009","article-title":"Mechanisms of immune-mediated liver injury","volume":"115","author":"Adams","year":"2010","journal-title":"Toxicol. Sci."},{"issue":"7","key":"10.1016\/j.fct.2020.111133_bib2","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.14309\/ajg.0000000000000115","article-title":"Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial","volume":"114","author":"Allegretti","year":"2019","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","article-title":"Bile acids induce inflammatory genes in hepatocytes: a novel mechanism of inflammation during obstructive cholestasis","volume":"178","author":"Allen","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib4","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/hep.24537","article-title":"Dual farnesoid X receptor\/TGR5 agonist INT-767 reduces liver injury in the Mdr2-\/- (Abcb4-\/-) mouse cholangiopathy model by promoting biliary HCO(-)(3) output","volume":"54","author":"Baghdasaryan","year":"2011","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/hep.510260102","article-title":"Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver","volume":"26","author":"Benedetti","year":"1997","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.fct.2020.111133_bib6","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/s41385-018-0066-8","article-title":"Natural killer T cells mediate inflammation in the bile ducts","volume":"11","author":"Berntsen","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"9","key":"10.1016\/j.fct.2020.111133_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162286","article-title":"Macrophage depletion attenuates extracellular matrix deposition and ductular reaction in a mouse model of chronic cholangiopathies","volume":"11","author":"Best","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib8","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1002\/hep.23810","article-title":"The biliary HCO(3)(-) umbrella: a unifying hypothesis on pathogenetic and therapeutic aspects of fibrosing cholangiopathies","volume":"52","author":"Beuers","year":"2010","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib9","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/cpt.744","article-title":"The NTCP-inhibitor myrcludex B: effects on bile acid disposition and tenofovir pharmacokinetics","volume":"103","author":"Blank","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.fct.2020.111133_bib10","doi-asserted-by":"crossref","first-page":"G833","DOI":"10.1152\/ajpgi.00228.2010","article-title":"Alterations of serum protein N-glycosylation in two mouse models of chronic liver disease are hepatocyte and not B cell driven","volume":"300","author":"Blomme","year":"2011","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.fct.2020.111133_bib11","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2019.04.005","article-title":"Therapeutic trials of biologics in primary biliary cholangitis: an open label study of abatacept and review of the literature","volume":"101","author":"Bowlus","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.fct.2020.111133_bib12","article-title":"Long-term obeticholic acid therapy improves histological endpoints in patients with primary biliary cholangitis","author":"Bowlus","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib13","article-title":"Studies on the mechanisms of bile acid initiated hepatic inflammation in cholestatic liver injury","volume":"4","author":"Cai","year":"2017","journal-title":"Inflamm Cell Signal"},{"issue":"5","key":"10.1016\/j.fct.2020.111133_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.90780","article-title":"Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response","volume":"2","author":"Cai","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib15","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/gast.2002.35953","article-title":"Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis","volume":"123","author":"Canbay","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib16","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.28550","article-title":"Soluble adenylyl cyclase regulates bile salt-induced apoptosis in human cholangiocytes","volume":"64","author":"Chang","year":"2016","journal-title":"Hepatology"},{"issue":"4 Pt B","key":"10.1016\/j.fct.2020.111133_bib17","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.bbadis.2017.09.022","article-title":"Role of the bicarbonate-responsive soluble adenylyl cyclase in cholangiocyte apoptosis in primary biliary cholangitis; a new hypothesis","volume":"1864","author":"Chang","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Comp. Physiol."},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3727\/105221618X15156018385515","article-title":"Bile acid metabolism in liver pathobiology","volume":"18","author":"Chiang","year":"2018","journal-title":"Gene Expr."},{"key":"10.1016\/j.fct.2020.111133_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev-nutr-082018-124344","article-title":"Bile acids as metabolic regulators and nutrient sensors","volume":"39","author":"Chiang","year":"2019","journal-title":"Annu. Rev. Nutr."},{"issue":"9","key":"10.1016\/j.fct.2020.111133_bib21","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/liv.14165","article-title":"Additional fibrate treatment in UDCA-refractory PBC patients","volume":"39","author":"Chung","year":"2019","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-0030-1253228","article-title":"Oxidative stress and the pathogenesis of cholestasis","volume":"30","author":"Copple","year":"2010","journal-title":"Semin. Liver Dis."},{"issue":"23","key":"10.1016\/j.fct.2020.111133_bib23","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1056\/NEJMoa1714519","article-title":"A placebo-controlled trial of bezafibrate in primary biliary cholangitis","volume":"378","author":"Corpechot","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/0192623312451160","article-title":"Effects of Kupffer cell depletion on acute alpha-naphthylisothiocyanate-induced liver toxicity in male mice","volume":"41","author":"Cullen","year":"2013","journal-title":"Toxicol. Pathol."},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib25","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but nonestablished primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.fct.2020.111133_bib26","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/hep.23911","article-title":"Conjugation is essential for the anticholestatic effect of NorUrsodeoxycholic acid in taurolithocholic acid-induced cholestasis in rat liver","volume":"52","author":"Denk","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib27","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbrc.2012.07.029","article-title":"Tauro-beta-muricholic acid restricts bile acid-induced hepatocellular apoptosis by preserving the mitochondrial membrane potential","volume":"424","author":"Denk","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib28","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/hep.21796","article-title":"Differential priming of CD8 and CD4 T-cells in animal models of autoimmune hepatitis and cholangitis","volume":"46","author":"Derkow","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib29","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/hep.24044","article-title":"B cell depletion therapy exacerbates murine primary biliary cirrhosis","volume":"53","author":"Dhirapong","year":"2011","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib30","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/hep.26067","article-title":"Therapeutic effect of cytotoxic T lymphocyte antigen 4\/immunoglobulin on a murine model of primary biliary cirrhosis","volume":"57","author":"Dhirapong","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib31","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jhep.2012.02.014","article-title":"Effect of ursodeoxycholic acid on bile acid profiles and intestinal detoxification machinery in primary biliary cirrhosis and health","volume":"57","author":"Dilger","year":"2012","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/jhep.2001.26213","article-title":"Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver","volume":"34","author":"Donner","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.fct.2020.111133_bib33","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jhep.2014.02.011","article-title":"Influence of CD8 T cell priming in liver and gut on the enterohepatic circulation","volume":"60","author":"Eickmeier","year":"2014","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/hep.1840400427","article-title":"Bile acids induce mitochondrial ROS, which promote activation of receptor tyrosine kinases and signaling pathways in rat hepatocytes","volume":"40","author":"Fang","year":"2004","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib35","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","article-title":"Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles","volume":"123","author":"Fickert","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2353\/ajpath.2006.050404","article-title":"Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice","volume":"168","author":"Fickert","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"European PSCnSG. norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib38","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.gastro.2005.11.015","article-title":"Kupffer cells abrogate cholestatic liver injury in mice","volume":"130","author":"Gehring","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.fct.2020.111133_bib39","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.6050","article-title":"Characterization of time-related changes after experimental bile duct ligation","volume":"95","author":"Georgiev","year":"2008","journal-title":"Br. J. Surg."},{"issue":"10","key":"10.1016\/j.fct.2020.111133_bib40","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","article-title":"Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis","volume":"138","author":"Gershwin","year":"1987","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib41","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.30213","article-title":"Bile microinfarcts in cholestasis are initiated by rupture of the apical hepatocyte membrane and cause shunting of bile to sinusoidal blood","volume":"69","author":"Ghallab","year":"2019","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.fct.2020.111133_bib42","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S1590-8658(02)80033-0","article-title":"Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease","volume":"34","author":"Guicciardi","year":"2002","journal-title":"Dig. Liver Dis."},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib43","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1053\/jhep.2002.32931","article-title":"Ursodeoxycholic acid cytoprotection: dancing with death receptors and survival pathways","volume":"35","author":"Guicciardi","year":"2002","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib44","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jhep.2018.05.018","article-title":"Macrophages contribute to the pathogenesis of sclerosing cholangitis in mice","volume":"69","author":"Guicciardi","year":"2018","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.fct.2020.111133_bib45","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/hep4.1356","article-title":"Liver macrophages: old dogmas and new insights","volume":"3","author":"Guillot","year":"2019","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/jhep.2003.50341","article-title":"Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice","volume":"38","author":"Gujral","year":"2003","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib47","doi-asserted-by":"crossref","first-page":"G499","DOI":"10.1152\/ajpgi.00318.2003","article-title":"Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice","volume":"286","author":"Gujral","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"Suppl. 1","key":"10.1016\/j.fct.2020.111133_bib48","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1186\/1476-5926-2-S1-S48","article-title":"Chlorotyrosine protein adducts are reliable biomarkers of neutrophil-induced cytotoxicity in vivo","volume":"3","author":"Gujral","year":"2004","journal-title":"Comp. Hepatol."},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib49","first-page":"998","article-title":"Reduced oncotic necrosis in Fas receptor-deficient C57BL\/6J-lpr mice after bile duct ligation","volume":"40","author":"Gujral","year":"2004","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.fct.2020.111133_bib50","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/hep.510260604","article-title":"Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis","volume":"26","author":"Harada","year":"1997","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1053\/j.gastro.2014.12.005","article-title":"Efficacy of obeticholic acid in patients with primary biliary cirrhosis and inadequate response to ursodeoxycholic acid","volume":"148","author":"Hirschfield","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28359","article-title":"Ustekinumab for patients with primary biliary cholangitis who have an inadequate response to ursodeoxycholic acid: a proof-of-concept study","volume":"64","author":"Hirschfield","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1159\/000324687","article-title":"Biliary bicarbonate secretion constitutes a protective mechanism against bile acid-induced injury in man","volume":"29","author":"Hohenester","year":"2011","journal-title":"Dig. Dis."},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24691","article-title":"A biliary HCO3- umbrella constitutes a protective mechanism against bile acid-induced injury in human cholangiocytes","volume":"55","author":"Hohenester","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2020.111133_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/hep.30552","article-title":"Bezafibrate improves GLOBE and UK-PBC scores and long-term outcomes in patients with primary biliary cholangitis","author":"Honda","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2020.111133_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jaut.2014.01.034","article-title":"Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells","volume":"50","author":"Huang","year":"2014","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.fct.2020.111133_bib57","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1084\/jem.20051911","article-title":"NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis","volume":"203","author":"Irie","year":"2006","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.fct.2020.111133_bib58","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1478-3231.2007.01465.x","article-title":"IL-8 expression by biliary epithelial cells is associated with neutrophilic infiltration and reactive bile ductules","volume":"27","author":"Isse","year":"2007","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib59","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ajpath.2018.11.010","article-title":"Loss of wnt secretion by macrophages promotes hepatobiliary injury after administration of 3,5-diethoxycarbonyl-1, 4-dihydrocollidine diet","volume":"189","author":"Jiang","year":"2019","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib60","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/hep.510300123","article-title":"Breakdown of tolerance to pyruvate dehydrogenase complex in experimental autoimmune cholangitis: a mouse model of primary biliary cirrhosis","volume":"30","author":"Jones","year":"1999","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib61","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/toxsci\/kfj111","article-title":"Early growth response factor-1 is critical for cholestatic liver injury","volume":"90","author":"Kim","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib62","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.27956","article-title":"Na(+)\/H(+) exchanger regulatory factor 1 knockout mice have an attenuated hepatic inflammatory response and are protected from cholestatic liver injury","volume":"62","author":"Li","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib63","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1189\/jlb.0313137","article-title":"Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils","volume":"94","author":"Licata","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib64","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.taap.2010.11.002","article-title":"Tissue factor contributes to neutrophil CD11b expression in alpha-naphthylisothiocyanate-treated mice","volume":"250","author":"Luyendyk","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"9","key":"10.1016\/j.fct.2020.111133_bib65","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0167-5699(89)90088-1","article-title":"Molecular basis of mitochondrial autoreactivity in primary biliary cirrhosis","volume":"10","author":"Mackay","year":"1989","journal-title":"Immunol. Today"},{"issue":"2 Suppl. 1","key":"10.1016\/j.fct.2020.111133_bib66","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1002\/hep.21062","article-title":"Apoptosis and necrosis in the liver: a tale of two deaths?","volume":"43","author":"Malhi","year":"2006","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib67","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cld.2015.08.003","article-title":"Making sense of autoantibodies in cholestatic liver diseases","volume":"20","author":"Marzorati","year":"2016","journal-title":"Clin. Liver Dis."},{"issue":"6","key":"10.1016\/j.fct.2020.111133_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061295","article-title":"Interleukin-1 receptor antagonist modulates liver inflammation and fibrosis in mice in a model-dependent manner","volume":"20","author":"Meier","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib69","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.fct.2020.111133_bib70","article-title":"TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function","author":"Merlen","year":"2019","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.fct.2020.111133_bib71","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.23238","article-title":"B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice","volume":"50","author":"Moritoki","year":"2009","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.fct.2020.111133_bib72","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ajg.2013.51","article-title":"B-cell depletion with rituximab in patients with primary biliary cirrhosis refractory to ursodeoxycholic acid","volume":"108","author":"Myers","year":"2013","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib73","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41564-018-0333-1","article-title":"Gut pathobionts underlie intestinal barrier dysfunction and liver T helper 17 cell immune response in primary sclerosing cholangitis","volume":"4","author":"Nakamoto","year":"2019","journal-title":"Nat Microbiol"},{"issue":"7","key":"10.1016\/j.fct.2020.111133_bib74","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.fct.2020.111133_bib75","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.ajpath.2013.07.019","article-title":"IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis","volume":"183","author":"O'Brien","year":"2013","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib76","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1002\/hep.24229","article-title":"Drug-induced cholestasis","volume":"53","author":"Padda","year":"2011","journal-title":"Hepatology"},{"issue":"2\u20133","key":"10.1016\/j.fct.2020.111133_bib77","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12016-014-8442-y","article-title":"Animal models in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"48","author":"Pollheimer","year":"2015","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib78","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/hep.20646","article-title":"Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial","volume":"41","author":"Rautiainen","year":"2005","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib79","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2015-309458","article-title":"TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro","volume":"65","author":"Reich","year":"2016","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib80","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/ajg.2017.287","article-title":"Effects of bezafibrate on outcome and pruritus in primary biliary cholangitis with suboptimal ursodeoxycholic acid response","volume":"113","author":"Reig","year":"2018","journal-title":"Am. J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib81","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0925-4439(02)00224-7","article-title":"Mitochondrially mediated synergistic cell killing by bile acids","volume":"1637","author":"Rolo","year":"2003","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib82","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.2009.03898.x","article-title":"Imbalance between T helper type 17 and T regulatory cells in patients with primary biliary cirrhosis: the serum cytokine profile and peripheral cell population","volume":"156","author":"Rong","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"12","key":"10.1016\/j.fct.2020.111133_bib83","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2169\/internalmedicine.2330-18","article-title":"Successful treatment of nivolumab-related cholangitis with prednisolone: a case report and review of the literature","volume":"58","author":"Sawada","year":"2019","journal-title":"Intern Med"},{"issue":"5","key":"10.1016\/j.fct.2020.111133_bib84","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.jhep.2013.12.027","article-title":"Reduced FOXP3(+) regulatory T cells in patients with primary sclerosing cholangitis are associated with IL2RA gene polymorphisms","volume":"60","author":"Sebode","year":"2014","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib85","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/hep.26702","article-title":"CD8 T cells primed in the gut-associated lymphoid tissue induce immune-mediated cholangitis in mice","volume":"59","author":"Seidel","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib86","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2013.09.021","article-title":"Perforin and granzymes work in synergy to mediate cholangiocyte injury in experimental biliary atresia","volume":"60","author":"Shivakumar","year":"2014","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.fct.2020.111133_bib87","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/hep.29251","article-title":"Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice","volume":"66","author":"Slijepcevic","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.fct.2020.111133_bib88","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29888","article-title":"Na(+) -taurocholate cotransporting polypeptide inhibition has hepatoprotective effects in cholestasis in mice","author":"Slijepcevic","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib89","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbamem.2006.10.008","article-title":"Regulation of transporter expression in mouse liver, kidney, and intestine during extrahepatic cholestasis","volume":"1768","author":"Slitt","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib90","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/01.MPG.0000170600.80640.88","article-title":"Human hepatic mitochondria generate reactive oxygen species and undergo the permeability transition in response to hydrophobic bile acids","volume":"41","author":"Sokol","year":"2005","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib91","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1053\/jhep.2001.23501","article-title":"Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver","volume":"33","author":"Soroka","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1172\/JCI116546","article-title":"Glycochenodeoxycholate-induced lethal hepatocellular injury in rat hepatocytes. Role of ATP depletion and cytosolic free calcium","volume":"92","author":"Spivey","year":"1993","journal-title":"J. Clin. Investig."},{"issue":"6","key":"10.1016\/j.fct.2020.111133_bib93","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1002\/hep.26993","article-title":"Cholangiocyte senescence by way of N-ras activation is a characteristic of primary sclerosing cholangitis","volume":"59","author":"Tabibian","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib94","doi-asserted-by":"crossref","first-page":"G498","DOI":"10.1152\/ajpgi.00482.2007","article-title":"CHOP deficiency attenuates cholestasis-induced liver fibrosis by reduction of hepatocyte injury","volume":"294","author":"Tamaki","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.fct.2020.111133_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102328","article-title":"The challenges of primary biliary cholangitis: what is new and what needs to be done","author":"Terziroli Beretta-Piccoli","year":"2019","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.fct.2020.111133_bib96","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3389\/fphar.2019.00837","article-title":"Mechanistic studies of idiosyncratic DILI: clinical implications","volume":"10","author":"Uetrecht","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib97","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/hep.27240","article-title":"Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype","volume":"61","author":"Vaz","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib98","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0016-5085(03)01068-0","article-title":"Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice","volume":"125","author":"Wagner","year":"2003","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.fct.2020.111133_bib99","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/hep.20903","article-title":"Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatic injury in mice","volume":"42","author":"Wang","year":"2005","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib100","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.24525","article-title":"The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light-chain enhancer of activated B cells (NF-kappaB) in mice","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology"},{"issue":"36","key":"10.1016\/j.fct.2020.111133_bib101","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.3748\/wjg.v18.i36.4985","article-title":"Novel insight into mechanisms of cholestatic liver injury","volume":"18","author":"Woolbright","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.fct.2020.111133_bib102","doi-asserted-by":"crossref","DOI":"10.3727\/105221619X15614873062730","article-title":"Inflammation and cell death during cholestasis: the evolving role of bile acids","author":"Woolbright","year":"2019","journal-title":"Gene Expr."},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib103","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.taap.2013.09.023","article-title":"Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice","volume":"273","author":"Woolbright","year":"2013","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib104","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.toxlet.2014.04.001","article-title":"Lithocholic acid feeding results in direct hepato-toxicity independent of neutrophil function in mice","volume":"228","author":"Woolbright","year":"2014","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib105","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.taap.2015.01.015","article-title":"Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis","volume":"283","author":"Woolbright","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.fct.2020.111133_bib106","first-page":"1018","article-title":"Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions","volume":"38","author":"Wu","year":"2003","journal-title":"Hepatology"},{"issue":"9\u201310","key":"10.1016\/j.fct.2020.111133_bib107","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.clinbiochem.2006.12.010","article-title":"Elevated apoptosis-associated cytokeratin 18 fragments (CK18Asp386) in serum of patients with chronic liver diseases indicate hepatic and biliary inflammation","volume":"40","author":"Yagmur","year":"2007","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.fct.2020.111133_bib108","doi-asserted-by":"crossref","DOI":"10.1053\/j.semdp.2019.07.009","article-title":"Checkpoint inhibitor-induced liver injury: a novel form of liver disease emerging in the era of cancer immunotherapy","author":"Zen","year":"2019","journal-title":"Semin. Diagn. Pathol."},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib109","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/hep.22651","article-title":"Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis","volume":"49","author":"Zhang","year":"2009","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.fct.2020.111133_bib110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1478-3231.2011.02662.x","article-title":"Effect of bile duct ligation on bile acid composition in mouse serum and liver","volume":"32","author":"Zhang","year":"2012","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.fct.2020.111133_bib111","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/hep.27121","article-title":"E2F1 is a novel fibrogenic gene that regulates cholestatic liver fibrosis through the Egr-1\/SHP\/EID1 network","volume":"60","author":"Zhang","year":"2014","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.fct.2020.111133_bib112","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/sji.12395","article-title":"Neutralization of interleukin-17 attenuates cholestatic liver fibrosis in mice","volume":"83","author":"Zhang","year":"2016","journal-title":"Scand. J. Immunol."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027869152030020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027869152030020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T21:56:52Z","timestamp":1759528612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027869152030020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":112,"alternative-id":["S027869152030020X"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2020.111133","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation: Cause or consequence of chronic cholestatic liver injury","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2020.111133","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111133"}}